These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34931191)

  • 1. Quantification of nuclear transport inhibition by SARS-CoV-2 ORF6 using a broadly applicable live-cell dose-response pipeline.
    Yoo TY; Mitchison T
    bioRxiv; 2022 Oct; ():. PubMed ID: 34931191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization.
    Yoo TY; Mitchison TJ
    Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2307997121. PubMed ID: 38236733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.
    Addetia A; Lieberman NAP; Phung Q; Hsiang TY; Xie H; Roychoudhury P; Shrestha L; Loprieno MA; Huang ML; Gale M; Jerome KR; Greninger AL
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Orf6 is positioned in the nuclear pore complex by Rae1 to inhibit nucleocytoplasmic transport.
    Makio T; Zhang K; Love N; Mast FD; Liu X; Elaish M; Hobman T; Aitchison JD; Fontoura BMA; Wozniak RW
    Mol Biol Cell; 2024 May; 35(5):ar62. PubMed ID: 38507240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Miorin L; Kehrer T; Sanchez-Aparicio MT; Zhang K; Cohen P; Patel RS; Cupic A; Makio T; Mei M; Moreno E; Danziger O; White KM; Rathnasinghe R; Uccellini M; Gao S; Aydillo T; Mena I; Yin X; Martin-Sancho L; Krogan NJ; Chanda SK; Schotsaert M; Wozniak RW; Ren Y; Rosenberg BR; Fontoura BMA; García-Sastre A
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28344-28354. PubMed ID: 33097660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanism of SARS-CoVs Orf6 Targeting the Rae1-Nup98 Complex to Compete With mRNA Nuclear Export.
    Li T; Wen Y; Guo H; Yang T; Yang H; Ji X
    Front Mol Biosci; 2021; 8():813248. PubMed ID: 35096974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhhadou M; Crossland NA; Barrall E; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena N; Aslam S; Saqi A; Marin A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    bioRxiv; 2022 Nov; ():. PubMed ID: 36299428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.
    Frieman M; Yount B; Heise M; Kopecky-Bromberg SA; Palese P; Baric RS
    J Virol; 2007 Sep; 81(18):9812-24. PubMed ID: 17596301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport.
    Gao X; Tian H; Zhu K; Li Q; Hao W; Wang L; Qin B; Deng H; Cui S
    Nat Commun; 2022 Aug; 13(1):4782. PubMed ID: 35970938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex.
    Kato K; Ikliptikawati DK; Kobayashi A; Kondo H; Lim K; Hazawa M; Wong RW
    Biochem Biophys Res Commun; 2021 Jan; 536():59-66. PubMed ID: 33360543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism.
    Huang SH; Lee TY; Lin YJ; Wan L; Lai CH; Lin CW
    J Microbiol Immunol Infect; 2017 Jun; 50(3):277-285. PubMed ID: 26320399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism.
    Wong HT; Cheung V; Salamango DJ
    J Cell Sci; 2022 Mar; 135(6):. PubMed ID: 35187564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
    Miyamoto Y; Itoh Y; Suzuki T; Tanaka T; Sakai Y; Koido M; Hata C; Wang CX; Otani M; Moriishi K; Tachibana T; Kamatani Y; Yoneda Y; Okamoto T; Oka M
    Commun Biol; 2022 May; 5(1):483. PubMed ID: 35590097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
    Schroeder S; Pott F; Niemeyer D; Veith T; Richter A; Muth D; Goffinet C; Müller MA; Drosten C
    Lancet Microbe; 2021 May; 2(5):e210-e218. PubMed ID: 33969329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).
    Park N; Schweers NJ; Gustin KE
    J Virol; 2015 Nov; 89(21):11069-79. PubMed ID: 26311873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion.
    Gori Savellini G; Anichini G; Gandolfo C; Cusi MG
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
    Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH
    Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor.
    Lee JG; Huang W; Lee H; van de Leemput J; Kane MA; Han Z
    Cell Biosci; 2021 Mar; 11(1):58. PubMed ID: 33766124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A putative diacidic motif in the SARS-CoV ORF6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs.
    Gunalan V; Mirazimi A; Tan YJ
    BMC Res Notes; 2011 Oct; 4():446. PubMed ID: 22026976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.